Comparative Safety and Effectiveness of Denosumab Versus Zoledronic Acid in Patients With Osteoporosis: A Cohort Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative Safety and Effectiveness of Denosumab Versus Zoledronic Acid in Patients With Osteoporosis: A Cohort Study

Published:2017-02-07 Issue:3 Volume:32 Page:611-617
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Choi Nam-Kyong¹²³,Solomon Daniel H¹⁴,Tsacogianis Theodore N¹,Landon Joan E¹,Song Hong Ji⁵,Kim Seoyoung C¹⁴

Affiliation:

1. Division of Pharmacoepidemiology and Pharmacoeconomics; Brigham and Women's Hospital and Harvard Medical School; Boston MA USA

2. Institute of Environmental Medicine; Medical Research Center; Seoul National University; Seoul Republic of Korea

3. Department of Health Convergence; Ewha Womans University; Seoul Republic of Korea

4. Division of Rheumatology; Immunology and Allergy; Brigham and Women's Hospital; Boston MA USA

5. Department of Family Medicine; Health Promotion Center; Hallym University Sacred Heart Hospital; Anyang Republic of Korea

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jbmr.3019/fullpdf

Reference46 articles.

1. Denosumab for prevention of fractures in postmenopausal women with osteoporosis;Cummings;N Engl J Med,2009

2. The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study;Papapoulos;Osteoporos Int,2015

3. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation;Lacey;Cell,1998

4. Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab;Anastasilakis;Ther Clin Risk Manag,2012

5. Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis;Lewiecki;Drug Healthc Patient Saf,2011

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zoledronic acid: challenges and pitfalls amid rehabilitation in primary osteoporosis and beyond;Balneo and PRM Research Journal;2024-06-21

2. Targeting SAT1 prevents osteoporosis through promoting osteoclast apoptosis;Biomedicine & Pharmacotherapy;2024-06

3. Evaluating the comparability of osteoporosis treatments using propensity score and negative control outcome methods in UK and Denmark electronic health record databases;Journal of Bone and Mineral Research;2024-04-15

4. Pharmacological treatment of osteoporosis and prevention of fractures: recommendations for clinical practice;Vnitřní lékařství;2024-04-10

5. Comparison of the Efficacy of Zoledronate and Denosumab in Patients with Acute Osteoporotic Vertebral Compression Fractures: A Randomized Controlled Trial;Journal of Clinical Medicine;2024-04-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3